Citadel Advisors »

Immix Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $15k 10k 1.49
2022-03-31 $52k 22k 2.39
2021-12-31 $94k 27k 3.55

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Immix Biopharma

AIGH Capital Management
Bleichroeder
Cable Car Capital
Vanguard Group
Geode Capital Management
Royal Bank of Canada
Morgan Stanley
Tocqueville Asset Management
State Street Corporation
Northern Trust
Private Advisor
Invst
Commonwealth Equity Services
Tritonpoint Wealth
Squarepoint Ops

View all funds holding Immix Biopharma